Encouraging findings for Batten disease drug
The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH. Results from the study were recently published in The Journal of Neuroscience.
Mar 17, 2023
0
62
